一个青少年的单克隆IgG沉积的增殖性淋巴结膜炎成功地用daratumumab治疗
Eva Svabova1, Jakub Zieg2, Martina Sukova3
1Department of Pediatrics, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic. eva.svabova@fnmotol.cz.
Pediatric nephrology (Berlin, Germany)
|June 10, 2024
概括
在儿童中,具有单克隆IgG沉积 (PGNMID) 的增殖性淋巴结膜炎缺乏特定的治疗方法. 一名患有PGNMID的15岁男孩在针对CD38血细胞的达拉图穆马布治疗后显示出显著的脏改善.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 单克隆IgG沉积 (PGNMID) 的增殖性淋巴结膜炎是一种罕见的病,特别是在儿科患者中.
- 目前,PGNMID没有确立的特殊治疗方法,需要探索新的治疗方法.
更多相关视频
06:39Glomerular Outgrowth as an Ex Vivo Assay to Analyze Pathways Involved in Parietal Epithelial Cell Activation
Published on: August 19, 2020
5.6K
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)